Cameron Gray
Fondatore presso Itolerance, Inc.
Posizioni attive di Cameron Gray
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Viewpoint Molecular Targeting, Inc.
 Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Viewpoint Molecular Targeting, Inc. develops pharmaceutical drugs for diagnostic imaging and therapy for cancer. The firm?s radiopharmaceutical drugs are designed to specifically localize in cancerous tissues in the human body. The company was founded by Frances L. Johnson, Michael K. Schultz and Heyward H. Coleman in 2008 and is headquartered in Coralville, IA. | Direttore/Membro del Consiglio | - | - |
Itolerance, Inc.
 Itolerance, Inc. BiotechnologyHealth Technology Itolerance, Inc. is an American biotechnology company that specializes in developing regenerative medicines. The private company was founded by Cameron Gray and is currently led by CEO Anthony J. Japour. | Presidente | - | - |
| Fondatore | - | - |
Storia della carriera di Cameron Gray
Precedenti posizioni note di Cameron Gray
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CUE BIOPHARMA, INC. | Direttore/Membro del Consiglio | 01/06/2015 | 16/06/2022 |
| Amministratore Delegato | 01/06/2015 | 01/08/2016 | |
| Independent Dir/Board Member | 01/06/2015 | 16/06/2022 | |
Public Ventures LLC
 Public Ventures LLC Investment Banks/BrokersFinance Public Ventures LLC is a registered broker-dealer headquartered in Dallas, Texas. The firm was founded by Christopher Marlett and Anthony DiGiandomenico in 1997. They are a wholly-owned subsidiary of MDB Capital Holdings LLC. Public Ventures offers Go-to-Market Strategy, Market Assessments, Revenue Generation and Product Strategy for technology companies that targets the Public Sector. | Corporate Officer/Principal | 01/09/2013 | 01/11/2019 |
| PROVENTION BIO, INC. | Direttore/Membro del Consiglio | 01/04/2017 | 29/05/2019 |
| ENDEAVOR IP INC | Direttore/Membro del Consiglio | 01/05/2013 | 03/01/2014 |
| Amministratore Delegato | 01/05/2013 | 03/01/2014 | |
| Direttore Finanziario/CFO | 01/05/2013 | 03/01/2014 | |
| Segretario Aziendale | 01/05/2013 | 03/01/2014 | |
| Treasurer | 01/05/2013 | 03/01/2014 | |
ICAP Patent Brokerage LLC
 ICAP Patent Brokerage LLC Real Estate DevelopmentFinance ICAP Patent Brokerage LLC provides intellectual property brokerage, live patent auction, and sealed-bid patent auction services. It operates a live auctioning platform for the buyers and sellers of patents and other intellectual property assets. The company is headquartered in New York, NY. | Corporate Officer/Principal | 01/01/2009 | 01/01/2012 |
| Alcedo Capital, Inc. | Fondatore | 01/12/2019 | - |
Formazione di Cameron Gray
| George Washington University Law School | Graduate Degree |
| University of Virginia | Doctorate Degree |
| Princeton University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 12 |
Posizioni
| Director/Board Member | 4 |
| Chief Executive Officer | 2 |
| Corporate Officer/Principal | 2 |
Settori
| Consumer Services | 4 |
| Health Technology | 4 |
| Commercial Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CUE BIOPHARMA, INC. | Health Technology |
| Aziende private | 7 |
|---|---|
Endeavor IP, Inc.
 Endeavor IP, Inc. Miscellaneous Commercial ServicesCommercial Services Endeavor IP, Inc. engages in the acquisition, development, and commercialization of intellectual property assets. The company was founded on December 8, 2009 and is headquartered in Vienna, VA. | Commercial Services |
ICAP Patent Brokerage LLC
ICAP Patent Brokerage LLC Real Estate DevelopmentFinance ICAP Patent Brokerage LLC provides intellectual property brokerage, live patent auction, and sealed-bid patent auction services. It operates a live auctioning platform for the buyers and sellers of patents and other intellectual property assets. The company is headquartered in New York, NY. | Finance |
Provention Bio, Inc.
 Provention Bio, Inc. Pharmaceuticals: MajorHealth Technology Provention Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics and solutions. Its products include PRV-031 for the interception of type 1 diabetes (T1D), PRV-015 for the treatment of gluten-free diet non-responding celiac disease, PRV-6527 for Crohn’s disease, PRV-3279 for the treatment of lupus, and PRV-101 for the prevention of acute coxsackie virus B (CVB), and the prevention of type 1 diabetes (T1D) onset. The company was founded by Francisco Leon and Ashleigh Palmer on October 4, 2016 and is headquartered in Red Bank, NJ. | Health Technology |
Public Ventures LLC
Public Ventures LLC Investment Banks/BrokersFinance Public Ventures LLC is a registered broker-dealer headquartered in Dallas, Texas. The firm was founded by Christopher Marlett and Anthony DiGiandomenico in 1997. They are a wholly-owned subsidiary of MDB Capital Holdings LLC. Public Ventures offers Go-to-Market Strategy, Market Assessments, Revenue Generation and Product Strategy for technology companies that targets the Public Sector. | Finance |
Viewpoint Molecular Targeting, Inc.
Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Viewpoint Molecular Targeting, Inc. develops pharmaceutical drugs for diagnostic imaging and therapy for cancer. The firm?s radiopharmaceutical drugs are designed to specifically localize in cancerous tissues in the human body. The company was founded by Frances L. Johnson, Michael K. Schultz and Heyward H. Coleman in 2008 and is headquartered in Coralville, IA. | Commercial Services |
Itolerance, Inc.
Itolerance, Inc. BiotechnologyHealth Technology Itolerance, Inc. is an American biotechnology company that specializes in developing regenerative medicines. The private company was founded by Cameron Gray and is currently led by CEO Anthony J. Japour. | Health Technology |
| Alcedo Capital, Inc. |
- Borsa valori
- Insiders
- Cameron Gray
- Esperienza
